Clinical Trial Update: High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/2 clinical trial evaluating high-dose megestrol acetate in patients with metastatic breast cancer, endometrial cancer, or maligna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Malignant Mesothelioma

Drugs mentioned

• Megace (megestrol acetate)

Snippet

Sponsor: St. Vincent Medical Center - Los Angeles | Conditions: Breast Cancer, Endometrial Cancer | Phase 1, Phase 2 | Status: UNKNOWN